Inovio Pharmaceuticals, Inc.
INO
$1.31
-$0.01-0.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 74.44% | 0.06% | 119.43% | -80.79% | 27.04% |
| Total Depreciation and Amortization | 3.26% | 0.27% | -2.80% | -2.12% | -10.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -774.63% | 63.81% | -6,040.89% | 13,070.10% | 31.62% |
| Change in Net Operating Assets | -281.89% | 68.28% | -421.04% | 74.46% | -94.69% |
| Cash from Operations | 13.28% | 19.66% | 1.49% | 21.39% | 26.23% |
| Capital Expenditure | -- | -- | -- | -- | 93.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.69% | 34,582.89% | -99.80% | -36.53% | -49.00% |
| Cash from Investing | 16.37% | 5,188.61% | -100.17% | -37.01% | -47.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -1.64% | 107.43% | 1,089.82% | -100.00% |
| Repurchase of Common Stock | -60.92% | -75.47% | -- | 71.88% | 85.51% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Financing | 49,396.26% | -7.21% | -6.90% | 3,672.68% | -100.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 133.76% | 30.49% | -82.54% | 196.15% | -205.23% |